Vivo Capital, LLC — 13F holdings

Vivo Capital, LLC reported 47 holdings worth $1.10B in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. TRVI TREVI THERAPEUTICS INC — $95.0M (8.7%)
2. PRAX PRAXIS PRECISION MEDICINES I — $90.8M (8.3%)
3. ERAS ERASCA INC — $75.6M (6.9%)
4. AVBP ARRIVENT BIOPHARMA INC — $58.4M (5.3%)
5. ABVX ABIVAX SA — $55.3M (5.0%)
6. TNGX TANGO THERAPEUTICS INC — $43.1M (3.9%)
7. CRVS CORVUS PHARMACEUTICALS INC — $41.9M (3.8%)
8. DRUG BRIGHT MINDS BIOSCIENCES INC — $39.1M (3.6%)
9. SVA SINOVAC BIOTECH LTD — $38.2M (3.5%)
10. TENX TENAX THERAPEUTICS INC — $36.4M (3.3%)